Eli Lilly Corp. buy Wells Fargo & Company
Start price
24.01.24
/
50%
€584.00
Target price
24.01.25
€641.90
Performance (%)
49.21%
Price
30.08.24
€867.80
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Eli Lilly Corp. has seen massive gains of 49.21%. Dividends of €3.59 are taken into consideration when calculating the performance. This prediction currently runs until 24.01.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eli Lilly Corp. | 2.010% | 2.010% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Wells Fargo & Company from $650.00 to $700.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€656.50
06.02.24
06.02.24
€766.92
06.02.25
06.02.25
32.73%
30.08.24
30.08.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€535.00
09.10.23
09.10.23
€616.85
09.10.24
09.10.24
63.07%
30.08.24
30.08.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€471.80
08.08.23
08.08.23
€561.00
08.08.24
08.08.24
64.96%
09.08.24
09.08.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€307.70
13.03.23
13.03.23
€350.10
13.03.24
13.03.24
124.73%
14.03.24
14.03.24